A screening system for Chinese patent medicine based on evidence-based medicine
By adjusting the classification type, storage capacity and backup cycle in the Chinese patent medicine screening system, the problems of insufficient data classification type and low storage capacity in the Chinese patent medicine screening system are solved, and the screening accuracy and stability of the system are improved.
Patent Information
- Application Number
- CN202311865475.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-29
- Publication Date
- 2024-12-10
- Estimated Expiration
- 2043-12-29
AI Technical Summary
In the existing clinical skills evaluation system of traditional Chinese medicine based on big data analysis, the insufficient number of clinical characteristics of traditional Chinese patent medicines and the proportion of data storage capacity is too low, resulting in a decrease in the screening accuracy and operation stability of the screening system.
Design a Chinese patent medicine screening system based on evidence-based medicine, including data collection module, screening module, storage module and control module, adjust the number of classification types through the difference between the average reduction amount of disease indicators in clinical trials and the standard reduction amount, according to the Chinese The variance of the proportion of missing words in the patent drug name adjusts the proportion of storage capacity, determines the backup period through the average screening time of the Chinese patent drug screening data, and re-determines the proportion of storage capacity based on the proportion of the output Chinese patent drug information.
The screening accuracy and operation stability of the Chinese patent medicine screening system are improved, and the system performance decline is reduced due to inaccurate classification types, inaccurate adjustment of storage capacity proportion and inaccurate adjustment of backup cycle.
Smart Images
Figure CN117809860B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of data processing, and in particular to a Chinese patent medicine screening system based on evidence-based medicine. Background Art
[0002] In the existing technology, evidence-based medicine has important value in the recommendation of Chinese patent medicine. Through scientific verification and clinical research on traditional herbal treatments, evidence-based medicine provides theoretical support and practical guidance for the selection of Chinese patent medicine. This approach integrates traditional medical knowledge and modern medical methods to ensure the safety and effectiveness of Chinese patent medicine. Selection based on clinical evidence enables doctors to apply Chinese patent medicine more accurately, improve treatment effects, and provide patients with more reliable health solutions.
[0003] Chinese Patent Publication No.: CN105528529B discloses a data processing method for a TCM clinical skills evaluation system based on big data analysis, including: a. Acquiring clinical electronic medical record data; b. Data preprocessing: Cleaning, converting, and loading the data obtained in step a; c. Data integration: Partitioning and storing the preprocessed data, and establishing an index and cache mechanism; d. Establishing a data analysis model: Performing data mining on the basis of data integration to obtain the scores of evaluation indicators in the TCM clinical skills digital evaluation system; the evaluation indicators include: five primary indicators: clinical efficacy indicators, dominant disease indicators, TCM diagnosis and treatment method indicators, work attitude indicators, and workload indicators; the secondary indicators of the clinical efficacy indicators include: follow-up rate, consultation rate, symptom improvement, and patient praise rate; the secondary indicators of the dominant disease indicators include: The first-level indicators include: ranking of single disease follow-up rate, ranking of single disease consultation rate, diagnosis and treatment time, symptom improvement, and patient satisfaction rate; the second-level indicators of the TCM diagnosis and treatment method indicators include: compliance rate of symptomatic medication with theory, method, prescription and medicine, and rate of combined use of Chinese and Western medicine; the second-level indicators of the work attitude indicators include: star rating of uploaded medical records and patient satisfaction rate; the second-level indicators of the workload indicators include: consultation rate and number of uploaded medical records; in the step d, the patient satisfaction rate indicator is graded and a score is assigned to each level, and the score corresponding to each level is the score of the patient satisfaction rate indicator; the uploaded medical record quantity indicator is graded and a score is assigned to each level, and the score corresponding to each level is the score of the uploaded medical record quantity. The uploaded medical record quantity indicator is the number of cases uploaded per unit time, and the score assigned to each level does not exceed the weight score corresponding to the indicator. It can be seen that the data processing method of the TCM clinical skills evaluation system based on big data analysis has problems such as the inability to accurately retrieve medicines suitable for the disease due to the small number of classification types of clinical characteristic data of Chinese patent medicines, and the low storage capacity of Chinese patent medicine data leading to the loss of historical data, which reduces the screening accuracy and operation stability of the screening system. Summary of the invention
[0004] To this end, the present invention provides a Chinese patent medicine screening system based on evidence-based medicine, which is used to overcome the problems in the prior art that the number of classification types of clinical characteristic data of Chinese patent medicines is too small, resulting in the inability to accurately retrieve medicines suitable for the symptoms, and the storage capacity of Chinese patent medicine data is too low, resulting in the loss of historical data, resulting in a decrease in the screening accuracy and operation stability of the screening system.
[0005] To achieve the above-mentioned purpose, the present invention provides a Chinese patent medicine screening system based on evidence-based medicine, comprising: a data acquisition module for collecting clinical characteristic data of Chinese patent medicines; a screening module, which is connected to the data acquisition module and is used to screen Chinese patent medicines with corresponding characteristics, including a classification component for classifying the clinical characteristic data of the Chinese patent medicines, and a comparison component connected to the classification component for comparing a number of Chinese patent medicines according to the Chinese patent medicine characteristic data to determine the Chinese patent medicines to be recommended; a storage module, which is respectively connected to the data acquisition module and the screening module, including a data storage component for storing the Chinese patent medicine characteristic data respectively and a data backup component connected to the data storage component for backing up the Chinese patent medicine characteristic data, wherein the Chinese patent medicine characteristic data Including clinical characteristic data and Chinese patent medicine screening data of the Chinese patent medicine; a control module, which is respectively connected to the data acquisition module, the screening module and the storage module, and is used to determine the number of classification types of the clinical characteristic data of the Chinese patent medicine according to the difference between the average reduction of the disease indicator of the clinical trial and the standard reduction, or, based on the difference between the average reduction of the disease indicator of the clinical trial and the standard reduction and the variance of the proportion of missing characters in the name of the Chinese patent medicine, determine the backup period of the Chinese patent medicine characteristic data based on the variance of the proportion of missing characters in the name of the Chinese patent medicine and the average screening time of the Chinese patent medicine screening data, and re-determine the storage capacity proportion of the Chinese patent medicine data based on the proportion of the freeze time of the output of the Chinese patent medicine information.
[0006] Furthermore, the calculation formula for the difference between the average reduction amount and the standard reduction amount of the disease indicator in the clinical trial is:
[0007]
[0008] Wherein, Q is the difference between the average reduction of the disease indicator in the clinical trial and the standard reduction, Qi is the reduction of the disease indicator in the i-th clinical trial, Q0 is the standard reduction, n is the number of clinical trials, and n is a natural number greater than or equal to 1.
[0009] Furthermore, the control module obtains the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount,
[0010] If the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount is greater than a preset second difference amount, the control module determines the number of classification types of the clinical characteristic data of the Chinese patent medicine.
[0011] Furthermore, the number of classification types of the clinical characteristic data of the Chinese patent medicine is determined by the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount and a preset second difference amount.
[0012] Furthermore, if the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount is greater than the preset first difference amount and less than or equal to the preset second difference amount, the control module obtains the number of missing characters in the name of the Chinese patent medicine, and calculates the variance of the proportion of the number of missing characters in the name of the Chinese patent medicine according to the number of missing characters in the name of the Chinese patent medicine,
[0013] If the variance of the missing character ratio of the Chinese patent medicine name is greater than a preset first variance and less than or equal to a preset second variance, the control module determines the storage capacity ratio of the Chinese patent medicine data.
[0014] Furthermore, the storage capacity ratio of the Chinese patent medicine data is determined by the difference between the variance of the missing word ratio of the Chinese patent medicine name and a preset first variance.
[0015] Furthermore, if the variance of the missing word ratio of the Chinese patent medicine name is greater than the preset second variance, the control module obtains the screening time of the Chinese patent medicine screening data, and calculates the average screening time of the Chinese patent medicine screening data according to the screening time of the Chinese patent medicine screening data.
[0016] If the average screening time of the Chinese patent medicine screening data is greater than the preset screening time, the control module determines the backup period of the Chinese patent medicine characteristic data.
[0017] Furthermore, the backup period of the Chinese patent medicine characteristic data is determined by the difference between the average screening time of the Chinese patent medicine screening data and the preset screening time.
[0018] Further, when the storage capacity ratio of the Chinese patent medicine data is initially determined, the control module obtains the duration of the freeze in outputting the Chinese patent medicine information, and calculates the duration ratio of the freeze in outputting the Chinese patent medicine information according to the duration of the freeze in outputting the Chinese patent medicine information.
[0019] If the freezing time ratio of outputting the Chinese patent medicine information is greater than the preset time ratio, the control module redetermines the storage capacity ratio of the Chinese patent medicine data.
[0020] Furthermore, the storage capacity ratio of the Chinese patent medicine data is re-determined by the difference between the freezing time ratio of outputting the Chinese patent medicine information and the preset time ratio.
[0021] Compared with the prior art, the beneficial effect of the present invention lies in that the system of the present invention adjusts the number of classification types of clinical characteristic data of Chinese patent medicines according to the difference between the average reduction of disease indicators in clinical trials and the standard reduction by setting a data acquisition module, a screening module, a storage module and a control module, thereby reducing the impact of the excessive reduction of disease indicators in clinical trials and the decrease in system operation stability caused by inaccurate adjustment of the number of classification types of clinical characteristic data of Chinese patent medicines, and adjusts the storage capacity ratio of Chinese patent medicine data according to the variance of the proportion of missing characters in the names of Chinese patent medicines, thereby reducing the impact of inaccurate adjustment of the storage capacity ratio of Chinese patent medicine data The loss of historical data caused the system's screening accuracy to decrease. By adjusting the backup period of the Chinese patent medicine characteristic data according to the average screening time of the Chinese patent medicine screening data, the impact of the system's operating stability decreased due to the increase in screening time caused by the inaccurate adjustment of the backup period of the Chinese patent medicine characteristic data was reduced. By making a secondary adjustment to the storage capacity ratio of the Chinese patent medicine data according to the proportion of the freeze time of outputting the Chinese patent medicine information, the impact of the system's screening accuracy decreased due to the slow processing speed of the Chinese patent medicine characteristic data caused by the inaccurate secondary adjustment of the storage capacity ratio of the Chinese patent medicine data was reduced, thereby improving the screening accuracy and operating stability of the screening system.
[0022] Furthermore, the system of the present invention adjusts the number of classification types of clinical characteristic data of Chinese patent medicines by setting the difference between the average reduction of disease indicators in clinical trials and the standard reduction and a preset second difference, thereby reducing the impact of decreased operating stability of the system due to excessive reduction in disease indicators in clinical trials, and further improving the screening accuracy and operating stability of the screening system.
[0023] Furthermore, the system of the present invention adjusts the storage capacity ratio of Chinese patent medicine data by setting the difference between the variance of the missing character ratio of the Chinese patent medicine name and a preset first variance, thereby reducing the impact of the system's screening accuracy decreased due to missing historical data, and further improving the screening accuracy and operating stability of the screening system.
[0024] Furthermore, the system of the present invention adjusts the backup period of the characteristic data of the Chinese patent medicine by setting the difference between the average screening time of the Chinese patent medicine screening data and the preset screening time, thereby reducing the impact of the decrease in the operating stability of the system due to the increase in screening time, and further achieving the improvement of the screening accuracy and operating stability of the screening system.
[0025] Furthermore, the system of the present invention performs secondary adjustment on the storage capacity ratio of Chinese patent medicine data by setting the difference between the ratio of the freezing time for outputting Chinese patent medicine information and the preset ratio, thereby reducing the impact of the system's screening accuracy decreased due to the slower processing speed of Chinese patent medicine characteristic data, and further achieving improved screening accuracy and operational stability of the screening system. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 The overall structural block diagram of the Chinese patent medicine screening system based on evidence-based medicine according to an embodiment of the present invention;
[0027] Figure 2 It is a specific structural block diagram of a screening module of a Chinese patent medicine screening system based on evidence-based medicine according to an embodiment of the present invention;
[0028] Figure 3 A specific structural block diagram of a storage module of a Chinese patent medicine screening system based on evidence-based medicine according to an embodiment of the present invention;
[0029] Figure 4 The present invention is a block diagram of a connection structure in which a data acquisition module and a screening module are connected in a Chinese patent medicine screening system based on evidence-based medicine according to an embodiment of the present invention. DETAILED DESCRIPTION
[0030] In order to make the objects and advantages of the present invention more clearly understood, the present invention is further described below in conjunction with embodiments; it should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0031] The preferred embodiments of the present invention are described below with reference to the accompanying drawings. It should be understood by those skilled in the art that these embodiments are only used to explain the technical principles of the present invention and are not intended to limit the protection scope of the present invention.
[0032] It should be noted that, in the description of the present invention, terms such as "up", "down", "left", "right", "inside" and "outside" indicating directions or positional relationships are based on the directions or positional relationships shown in the drawings. This is merely for the convenience of description and does not indicate or imply that the device or element must have a specific orientation, be constructed and operated in a specific orientation. Therefore, it cannot be understood as a limitation on the present invention.
[0033] In addition, it should be noted that in the description of the present invention, unless otherwise clearly specified and limited, the terms "installed", "connected", and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be indirectly connected through an intermediate medium, or it can be the internal communication of two components. For those skilled in the art, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0034] See also Figure 1 , Figure 2 , Figure 3 as well as Figure 4 As shown, they are respectively an overall structural block diagram of a Chinese patent medicine screening system based on evidence-based medicine, a specific structural block diagram of a screening module, a specific structural block diagram of a storage module, and a connection structural block diagram of a data acquisition module connected to a screening module. A Chinese patent medicine screening system based on evidence-based medicine of the present invention comprises:
[0035] Data collection module, used to collect clinical characteristic data of Chinese patent medicines;
[0036] A screening module, which is connected to the data collection module and is used to screen Chinese patent medicines with corresponding characteristics, including a classification component for classifying the clinical characteristic data of the Chinese patent medicines, and a comparison component connected to the classification component for comparing a number of Chinese patent medicines according to the Chinese patent medicine characteristic data to determine the Chinese patent medicine to be recommended;
[0037] A storage module, which is connected to the data acquisition module and the screening module respectively, and includes a data storage component for storing the characteristic data of the Chinese patent medicine and a data backup component connected to the data storage component for backing up the characteristic data of the Chinese patent medicine, wherein the characteristic data of the Chinese patent medicine includes the clinical characteristic data of the Chinese patent medicine and the screening data of the Chinese patent medicine;
[0038] A control module, which is respectively connected to the data acquisition module, the screening module and the storage module, and is used to determine the number of classification types of the clinical characteristic data of the Chinese patent medicine according to the difference between the average reduction of the disease indicator of the clinical trial and the standard reduction, or to determine the storage capacity ratio of the Chinese patent medicine data based on the difference between the average reduction of the disease indicator of the clinical trial and the standard reduction and the variance of the missing word ratio of the Chinese patent medicine name, and to determine the backup period of the Chinese patent medicine characteristic data based on the variance of the missing word ratio of the Chinese patent medicine name and the average screening time of the Chinese patent medicine screening data, and to re-determine the storage capacity ratio of the Chinese patent medicine data based on the freeze time ratio of the output of the Chinese patent medicine information.
[0039] Specifically, the classification types of the clinical characteristic data of the Chinese patent medicine include the dosage form of the medicine, the type of disease the medicine treats, and the type of ingredients of the medicine.
[0040] Specifically, the variance of the proportion of missing characters in the names of the Chinese patent medicines is the variance of the proportion of missing characters in several Chinese patent medicine names. The calculation method of the variance of the proportion of missing characters in the names of the Chinese patent medicines is a conventional technical means well known to technical personnel in this field. Therefore, the calculation process of the variance of the proportion of missing characters in the names of the Chinese patent medicines will not be repeated here.
[0041] Specifically, the calculation formula for the percentage of missing characters in the names of the Chinese patent medicines is:
[0042]
[0043] Among them, E is the percentage of missing characters in the name of the Chinese patent medicine, F1 is the number of missing characters in the name of the Chinese patent medicine, and F is the total number of characters in the name of the Chinese patent medicine.
[0044] Specifically, when cleaning the clinical characteristic data of Chinese patent medicines, characters may be accidentally deleted, resulting in missing characters in the names of Chinese patent medicines.
[0045] Specifically, the calculation formula for the average screening time of the Chinese patent medicine screening data is:
[0046]
[0047] Among them, Z is the average screening time of Chinese patent medicine screening data, X a is the time taken to screen the a-th Chinese patent medicine screening data, n is the number of Chinese patent medicine screening data screened, and n is a natural number greater than or equal to 1.
[0048] Specifically, the calculation formula for the percentage of the freezing time of outputting the Chinese patent medicine information is:
[0049]
[0050] Among them, S is the percentage of the freezing time of outputting Chinese patent medicine information, T1 is the freezing time of outputting Chinese patent medicine information, and T is the total time of outputting Chinese patent medicine information.
[0051] The system of the present invention is provided with a data acquisition module, a screening module, a storage module and a control module, and adjusts the number of classification types of clinical characteristic data of Chinese patent medicines according to the difference between the average reduction amount of disease indicators in clinical trials and the standard reduction amount, thereby reducing the impact of the system's operational stability being reduced due to an excessive reduction amount of disease indicators in clinical trials caused by inaccurate adjustment of the number of classification types of clinical characteristic data of Chinese patent medicines, and adjusts the storage capacity ratio of Chinese patent medicine data according to the variance of the proportion of missing characters in the names of Chinese patent medicines, thereby reducing the loss of historical data due to inaccurate adjustment of the storage capacity ratio of Chinese patent medicine data In order to reduce the impact of decreased screening accuracy of the system, the backup period of Chinese patent medicine characteristic data is adjusted according to the average screening time of Chinese patent medicine screening data, thereby reducing the impact of decreased system operation stability caused by increased screening time due to inaccurate adjustment of the backup period of Chinese patent medicine characteristic data. By making a secondary adjustment to the storage capacity ratio of Chinese patent medicine data according to the proportion of the freeze time in outputting Chinese patent medicine information, the impact of decreased system screening accuracy caused by slower processing speed of Chinese patent medicine characteristic data due to inaccurate secondary adjustment of the storage capacity ratio of Chinese patent medicine data is reduced, thereby improving the screening accuracy and operation stability of the screening system.
[0052] Please continue reading Figure 2 As shown, the calculation formula for the difference between the average reduction amount of the disease indicator in the clinical trial and the standard reduction amount is:
[0053]
[0054] Wherein, Q is the difference between the average reduction of the disease indicator in the clinical trial and the standard reduction, Qi is the reduction of the disease indicator in the i-th clinical trial, Q0 is the standard reduction, n is the number of clinical trials, and n is a natural number greater than or equal to 1.
[0055] Please continue reading Figure 2 As shown, the control module obtains the difference between the average reduction amount and the standard reduction amount of the disease indicator of the clinical trial,
[0056] If the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount is greater than a preset first difference amount, the control module determines that the screening accuracy of the system is lower than the allowable range;
[0057] If the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount is greater than the preset first difference amount and less than or equal to the preset second difference amount, the control module preliminarily determines that the integrity of the Chinese patent medicine data is lower than the allowable range, and performs a secondary determination on the integrity of the Chinese patent medicine data based on the variance of the proportion of missing characters in the Chinese patent medicine name;
[0058] If the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount is greater than a preset second difference amount, the control module determines the number of classification types of the clinical characteristic data of the Chinese patent medicine.
[0059] Specifically, the difference between the average reduction of disease indicators in clinical trials and the standard reduction is recorded as K, the preset first difference is recorded as K1, and K1 is set to 7. The preset second difference is recorded as K2, and K2 is set to 8. The difference between the average reduction of disease indicators in clinical trials and the standard reduction and the preset second difference is recorded as △K, and △K is set to K-K2.
[0060] The system described in the present invention determines the screening accuracy of the system by setting a preset first difference amount and a preset second difference amount, thereby reducing the impact of the system's operating stability being reduced due to inaccurate judgment of the system's screening accuracy, and further improving the screening accuracy and operating stability of the screening system.
[0061] Please continue reading Figure 2 As shown, the number of classification types of the clinical characteristic data of the Chinese patent medicine is determined by the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount and the preset second difference amount.
[0062] Specifically, the specific process of determining the number of classification types of clinical characteristic data of Chinese patent medicines by the difference between the average reduction amount of the disease index of the clinical trial and the standard reduction amount and the preset second difference amount is:
[0063] The control module uses a preset first quantity adjustment coefficient to adjust the number of classification types of the clinical characteristic data of the Chinese patent medicine to a first number under a preset first difference difference condition; the preset first difference difference condition is that the difference between the average reduction amount and the standard reduction amount of the disease indicator of the clinical trial and the preset second difference amount is less than or equal to the preset difference difference;
[0064] The control module adjusts the number of classification types of the clinical characteristic data of the Chinese patent medicine to a second number using a preset second quantity adjustment coefficient under a preset second difference difference condition; the preset second difference difference condition is that the difference between the average reduction amount and the standard reduction amount of the disease indicator of the clinical trial and the preset second difference amount is greater than the preset difference difference;
[0065] Wherein, the preset first quantity adjustment coefficient is smaller than the preset second quantity adjustment coefficient.
[0066] Specifically, the preset difference value is recorded as △K0, △Q0 is set to 2, the preset first quantity adjustment coefficient is recorded as α1, α1 is set to 1.2, the preset second quantity adjustment coefficient is recorded as α2, α2 is set to 1.4, the number of classification types of clinical characteristic data of Chinese patent medicine is recorded as V, wherein 1<α1<α2, the number of classification types of clinical characteristic data of Chinese patent medicine after adjustment is recorded as V', V' is set to V×(1+αd) / 2, wherein αd is the preset i-th quantity adjustment coefficient, and d is set to 1, 2.
[0067] The system of the present invention adjusts the number of classification types of clinical characteristic data of Chinese patent medicines by setting the difference between the average reduction of disease indicators in clinical trials and the standard reduction and a preset second difference, thereby reducing the impact of a decrease in the operating stability of the system due to an excessively large reduction in disease indicators in clinical trials, and further achieving improved screening accuracy and operating stability of the screening system.
[0068] Please continue reading Figure 3 As shown, if the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount is greater than the preset first difference amount and less than or equal to the preset second difference amount, the control module obtains the number of missing characters in the name of the Chinese patent medicine, and calculates the variance of the proportion of the number of missing characters in the name of the Chinese patent medicine according to the number of missing characters in the name of the Chinese patent medicine.
[0069] If the variance of the missing word ratio of the Chinese patent medicine name is greater than the preset first variance, the control module determines for the second time that the integrity of the Chinese patent medicine data is lower than the allowable range;
[0070] If the variance of the missing word ratio of the Chinese patent medicine name is greater than the preset first variance and less than or equal to the preset second variance, the control module determines the storage capacity ratio of the Chinese patent medicine data;
[0071] If the variance of the proportion of missing characters in the name of the Chinese patent medicine is greater than the preset second variance, the control module preliminarily determines that the network security risk exceeds the allowable range, and makes a secondary judgment on the network security risk based on the average screening time of the Chinese patent medicine screening data.
[0072] Specifically, the preset first variance is recorded as P1, and P1 is set to 0.3. The preset second variance is recorded as P2, and P2 is set to 0.4. The variance of the proportion of missing characters in the names of Chinese patent medicines is recorded as P. The difference between the variance of the proportion of missing characters in the names of Chinese patent medicines and the preset first variance is recorded as △P, and △P is set to P-P1.
[0073] The system of the present invention performs a secondary determination on the integrity of the Chinese patent medicine data by setting a preset first variance and a preset second variance, thereby reducing the impact of the system's operational stability being reduced due to inaccurate secondary determination of the integrity of the Chinese patent medicine data, and further improving the screening accuracy and operational stability of the screening system.
[0074] Please continue reading Figure 3 As shown, the storage capacity ratio of the Chinese patent medicine data is determined by the difference between the variance of the missing word ratio of the Chinese patent medicine name and the preset first variance.
[0075] Specifically, the specific process of determining the storage capacity ratio of Chinese patent medicine data by the difference between the variance of the missing word ratio of the Chinese patent medicine name and the preset first variance is as follows:
[0076] The control module uses a preset first proportion adjustment coefficient to adjust the storage capacity proportion of the Chinese patent medicine data to a first proportion under a preset first variance difference condition; the preset first variance difference condition is that the difference between the variance of the missing word proportion of the Chinese patent medicine name and the preset first variance is less than or equal to the preset variance difference;
[0077] The control module uses a preset second proportion adjustment coefficient to adjust the storage capacity proportion of the Chinese patent medicine data to a second proportion under a preset second variance difference condition; the preset second variance difference condition is that the difference between the variance of the proportion of missing characters in the name of the Chinese patent medicine and the preset first variance is greater than the preset variance difference;
[0078] Among them, the preset first proportion adjustment coefficient is smaller than the preset second proportion adjustment coefficient.
[0079] Specifically, the preset variance difference is recorded as △P0, and △P0=0.01s 2 The preset first proportion adjustment coefficient is recorded as β1, and β1 is set to 1.1. The preset second proportion adjustment coefficient is recorded as β2, and β2 is set to 1.3. The storage capacity proportion of traditional Chinese medicine data is recorded as H, where 1<β1<β2. The adjusted storage capacity proportion of traditional Chinese medicine data is recorded as H', and H' is set to H×(1+2βj) / 3, where βj is the preset j-th proportion adjustment coefficient, and j is set to 1, 2.
[0080] The system of the present invention adjusts the storage capacity ratio of Chinese patent medicine data by setting the difference between the variance of the missing word ratio of the Chinese patent medicine name and a preset first variance, thereby reducing the impact of the system's screening accuracy decreased due to missing historical data, and further improving the screening accuracy and operating stability of the screening system.
[0081] Please continue reading Figure 3As shown, if the variance of the missing word ratio of the Chinese patent medicine name is greater than the preset second variance, the control module obtains the screening time of the Chinese patent medicine screening data, and calculates the average screening time of the Chinese patent medicine screening data according to the screening time of the Chinese patent medicine screening data.
[0082] If the average screening time of the Chinese patent medicine screening data is greater than the preset screening time, the control module determines for the second time that the network security risk exceeds the allowable range, and determines the backup period of the Chinese patent medicine characteristic data.
[0083] Specifically, the preset screening time is recorded as Y0, and Y0=0.03s is set. The average screening time of the Chinese patent medicine screening data is recorded as Y. The difference between the average screening time of the Chinese patent medicine screening data and the preset screening time is recorded as △Y, and △Y=Y-Y0 is set.
[0084] The system of the present invention performs a secondary judgment on network security risks by setting a preset screening time, thereby reducing the impact of the system's operational stability decreased due to inaccurate secondary judgment of network security risks, and further improving the screening accuracy and operational stability of the screening system.
[0085] Please continue reading Figure 3 As shown, the backup period of the Chinese patent medicine characteristic data is determined by the difference between the average screening time of the Chinese patent medicine screening data and the preset screening time.
[0086] Specifically, the specific process of determining the backup period of the Chinese patent medicine characteristic data by the difference between the average screening time of the Chinese patent medicine screening data and the preset screening time is as follows:
[0087] The control module uses a preset second period adjustment coefficient to adjust the backup period of the Chinese patent medicine characteristic data to the first period under a preset first screening time difference condition; the preset first screening time difference condition is that the difference between the average screening time of the Chinese patent medicine screening data and the preset screening time is less than or equal to the preset screening time difference;
[0088] The control module uses the preset first cycle adjustment coefficient to adjust the backup cycle of the Chinese patent medicine characteristic data to the second cycle under the preset second screening time difference condition; the preset second screening time difference condition is that the difference between the average screening time of the Chinese patent medicine screening data and the preset screening time is greater than the preset screening time difference;
[0089] Wherein, the preset first period adjustment coefficient is smaller than the preset second period adjustment coefficient.
[0090] Specifically, the preset screening time difference is recorded as △Y0, and △Y0 is set to 0.01s. The preset first cycle adjustment coefficient is recorded as γ1, and γ1 is set to 0.8. The preset second cycle adjustment coefficient is recorded as γ2, and γ2 is set to 0.9. The backup period of the Chinese patent medicine characteristic data is recorded as L, wherein 0<γ1<γ2<1. The backup period of the adjusted Chinese patent medicine characteristic data is recorded as L', and L'=L×(1+3γm) / 4, wherein γm is the preset mth cycle adjustment coefficient, and m=1,2.
[0091] The system of the present invention adjusts the backup period of the characteristic data of Chinese patent medicines by setting the difference between the average screening time of the screening data of Chinese patent medicines and the preset screening time, thereby reducing the impact of the decrease in the operating stability of the system due to the increase in screening time, and further improving the screening accuracy and operating stability of the screening system.
[0092] Please continue reading Figure 4 As shown, when the storage capacity ratio of the Chinese patent medicine data is initially determined, the control module obtains the duration of the freeze in outputting the Chinese patent medicine information, and calculates the freeze duration ratio of the Chinese patent medicine information according to the duration of the freeze in outputting the Chinese patent medicine information.
[0093] If the freezing time ratio of outputting the Chinese patent medicine information is greater than the preset time ratio, the control module determines that the processing effectiveness of the Chinese patent medicine data is lower than the allowable range, and redetermines the storage capacity ratio of the Chinese patent medicine data.
[0094] Specifically, the preset duration ratio is recorded as R0, and R0=0.3 is set. The duration ratio of the freeze in outputting Chinese patent medicine information is recorded as R. The difference between the duration ratio of the freeze in outputting Chinese patent medicine information and the preset duration ratio is recorded as △R, and △R=R-R0 is set.
[0095] The system described in the present invention determines the processing effectiveness of Chinese patent medicine data by setting a preset time ratio, thereby reducing the impact of the system's screening accuracy decreased due to inaccurate judgment of the processing effectiveness of Chinese patent medicine data, and further improving the screening accuracy and operating stability of the screening system.
[0096] Please continue reading Figure 4 As shown, the storage capacity ratio of the Chinese patent medicine data is re-determined by the difference between the stalling time ratio of outputting the Chinese patent medicine information and the preset time ratio.
[0097] Specifically, the specific process of re-determining the storage capacity ratio of the Chinese patent medicine data by the difference between the freezing duration ratio of outputting the Chinese patent medicine information and the preset duration ratio is as follows:
[0098] The control module uses a preset fourth proportion secondary adjustment coefficient to secondary adjust the storage capacity proportion of the Chinese patent medicine data to a third proportion under a preset first duration proportion difference condition; the preset first duration proportion difference condition is that the difference between the freezing duration proportion of outputting the Chinese patent medicine information and the preset duration proportion is less than or equal to the preset duration proportion difference;
[0099] The control module uses a preset third proportion secondary adjustment coefficient under a preset second duration proportion difference condition to secondary adjust the storage capacity proportion of the Chinese patent medicine data to a fourth proportion; the preset second duration proportion difference condition is that the difference between the freezing duration proportion of outputting the Chinese patent medicine information and the preset duration proportion is greater than the preset duration proportion difference;
[0100] Among them, the preset third proportion secondary adjustment coefficient is smaller than the preset fourth proportion secondary adjustment coefficient.
[0101] Specifically, the preset time duration ratio difference is recorded as △R0, and △R0 is set to 0.1. The preset third ratio secondary adjustment coefficient is recorded as β3, and β3 is set to 0.7. The preset fourth ratio secondary adjustment coefficient is recorded as β4, and β4 is set to 0.8, among which 0<β3<β4<1. The storage capacity ratio of the adjusted Chinese patent medicine data is recorded as H", and H" is set to H'×(1+2βw) / 3, among which βw is the preset wth ratio secondary adjustment coefficient, and w is set to 3, 4.
[0102] The system described in the present invention performs secondary adjustment on the storage capacity ratio of Chinese patent medicine data by setting the difference between the ratio of the freezing time for outputting Chinese patent medicine information and the preset ratio, thereby reducing the impact of the system's screening accuracy decreased due to the slower processing speed of Chinese patent medicine characteristic data, and further improving the screening accuracy and operation stability of the screening system.
[0103] Example 1
[0104] The control module described in this embodiment 1 adjusts the number of classification types of the clinical characteristic data of the Chinese patent medicine according to the difference between the average reduction of the disease indicator in the clinical trial and the standard reduction and the preset second difference, wherein the preset difference is recorded as △K0, the preset first quantity adjustment coefficient is recorded as α1, the preset second quantity adjustment coefficient is recorded as α2, and the number of classification types of the clinical characteristic data of the Chinese patent medicine is recorded as V, wherein 1<α1<α2, α1=1.2, α2=1.4, △K0=2, and V=20.
[0105] In this embodiment 1, △K=3 is obtained, and the data storage component determines that △K>△K0 and uses the preset first quantity adjustment coefficient to adjust the number of classification types of the clinical characteristic data of the Chinese patent medicine to the second number, and calculates that V'=20×(1+1.2) / 2=22.
[0106] So far, the technical solutions of the present invention have been described in conjunction with the preferred embodiments shown in the accompanying drawings. However, it is easy for those skilled in the art to understand that the protection scope of the present invention is obviously not limited to these specific embodiments. Without departing from the principle of the present invention, those skilled in the art can make equivalent changes or substitutions to the relevant technical features, and the technical solutions after these changes or substitutions will fall within the protection scope of the present invention.
Claims
1. A Chinese patent medicine screening system based on evidence-based medicine, characterized in that: include: Data collection module, used to collect clinical characteristic data of Chinese patent medicines; A screening module, which is connected to the data collection module and is used to screen Chinese patent medicines with corresponding characteristics, including a classification component for classifying the clinical characteristic data of the Chinese patent medicines, and a comparison component connected to the classification component for comparing a number of Chinese patent medicines according to the Chinese patent medicine characteristic data to determine the Chinese patent medicine to be recommended; A storage module, which is connected to the data acquisition module and the screening module respectively, and includes a data storage component for storing the characteristic data of the Chinese patent medicine and a data backup component connected to the data storage component for backing up the characteristic data of the Chinese patent medicine, wherein the characteristic data of the Chinese patent medicine includes the clinical characteristic data of the Chinese patent medicine and the screening data of the Chinese patent medicine; A control module, which is respectively connected to the data acquisition module, the screening module and the storage module, and is used to determine the number of classification types of clinical characteristic data of the Chinese patent medicine according to the difference between the average reduction of the disease indicator in the clinical trial and the standard reduction, determine the storage capacity ratio of the Chinese patent medicine data based on the difference between the average reduction of the disease indicator in the clinical trial and the standard reduction and the variance of the missing word ratio of the Chinese patent medicine name, determine the backup period of the Chinese patent medicine characteristic data based on the variance of the missing word ratio of the Chinese patent medicine name and the average screening time of the Chinese patent medicine screening data, and re-determine the storage capacity ratio of the Chinese patent medicine data based on the freeze time ratio of outputting the Chinese patent medicine information.
2. The Chinese patent medicine screening system based on evidence-based medicine according to claim 1, characterized in that: The calculation formula for the difference between the average reduction amount of the disease indicator in the clinical trial and the standard reduction amount is: Q= Wherein, Q is the difference between the average reduction of the disease indicator in the clinical trial and the standard reduction, Qi is the reduction of the disease indicator in the i-th clinical trial, Q0 is the standard reduction, n is the number of clinical trials, and n is a natural number greater than or equal to 1.
3. The Chinese patent medicine screening system based on evidence-based medicine according to claim 2, characterized in that: The control module obtains the difference between the average reduction amount and the standard reduction amount of the disease indicator of the clinical trial, If the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount is greater than a preset second difference amount, the control module determines the number of classification types of the clinical characteristic data of the Chinese patent medicine.
4. The Chinese patent medicine screening system based on evidence-based medicine according to claim 3, characterized in that: The number of classification types of the clinical characteristic data of the Chinese patent medicine is determined by the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount and a preset second difference amount.
5. The Chinese patent medicine screening system based on evidence-based medicine according to claim 4, characterized in that: If the difference between the average reduction amount of the disease indicator of the clinical trial and the standard reduction amount is greater than the preset first difference amount and less than or equal to the preset second difference amount, the control module obtains the number of missing characters in the name of the Chinese patent medicine, and calculates the variance of the proportion of the number of missing characters in the name of the Chinese patent medicine according to the number of missing characters in the name of the Chinese patent medicine, If the variance of the missing character ratio of the Chinese patent medicine name is greater than a preset first variance and less than or equal to a preset second variance, the control module determines the storage capacity ratio of the Chinese patent medicine data.
6. The Chinese patent medicine screening system based on evidence-based medicine according to claim 5, characterized in that: The storage capacity ratio of the Chinese patent medicine data is determined by the difference between the variance of the missing word ratio of the Chinese patent medicine name and a preset first variance.
7. The Chinese patent medicine screening system based on evidence-based medicine according to claim 6, characterized in that: If the variance of the missing word ratio of the Chinese patent medicine name is greater than the preset second variance, the control module obtains the screening time of the Chinese patent medicine screening data, and calculates the average screening time of the Chinese patent medicine screening data according to the screening time of the Chinese patent medicine screening data. If the average screening time of the Chinese patent medicine screening data is greater than the preset screening time, the control module determines the backup period of the Chinese patent medicine characteristic data.
8. The Chinese patent medicine screening system based on evidence-based medicine according to claim 7, characterized in that: The backup period of the Chinese patent medicine characteristic data is determined by the difference between the average screening time of the Chinese patent medicine screening data and the preset screening time.
9. The Chinese patent medicine screening system based on evidence-based medicine according to claim 8, characterized in that: When the storage capacity ratio of the Chinese patent medicine data is initially determined, the control module obtains the duration of the freeze in outputting the Chinese patent medicine information, and calculates the freeze duration ratio of the Chinese patent medicine information according to the duration of the freeze in outputting the Chinese patent medicine information. If the freezing time ratio of outputting the Chinese patent medicine information is greater than the preset time ratio, the control module redetermines the storage capacity ratio of the Chinese patent medicine data.
10. The Chinese patent medicine screening system based on evidence-based medicine according to claim 9, characterized in that: The storage capacity ratio of the Chinese patent medicine data is re-determined by the difference between the stall duration ratio of outputting the Chinese patent medicine information and the preset duration ratio.